why choose us

First received: November 23, 2022

Clinical Trial: A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: HERMES: Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

Brief Summary: This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation.Participants will either get ziltivekimab or placebo.The study is expected to last for up to 4 years.Participants will have up to 20 clinic visits.Participants will have to use a study app on their phone to record and share information about all their injections of study medicine and to fill in questionnaires.

Read more